Introduction
Constitutive activation of kinase-dependent signal transduction events has been shown to be a common event in AML. Most frequently, mutational activation of Flt3 by internal tandem duplications (FLT3-ITD) results in aberrant activation of several signaling pathways, often the activation of STAT3 and STAT5 proteins 1 . Recent studies showed clinical response of AML patients that were treated with EGFR inhibitors in early clinical trials 2, 3 . Subsequently, it was shown in an RNAi approach that in certain AML cell line models, gefitinib targeted spleen tyrosine kinase (Syk) and that these cells were dependent on Syk activity in vitro as well as in vivo 4 . Syk is a non-receptor tyrosine kinase that is expressed most in hematopoietic cells. Syk mediated signaling is crucial for many immune and non-immune biological responses and furthermore, aberrant expression or function of Syk is linked to a wide range of malignancies in hematopoietic and also in non-hematopoietic cell types [5] [6] [7] .
Interestingly, the role of Syk is disease-specific. For example, it has been shown that Syk acts as an oncoprotein in diffuse large B-cell lymphomas 6, 8 . However, the molecular mechanism of Syk function in AML cells has not been studied.
Therefore, we characterized the Syk signaling network in AML cells by applying quantitative proteomic strategies and uncovered a functional link between the ITAM-bearing Fc-γ chain, β 2 -integrins, Syk and the oncogenic transcription factors STAT3 and STAT5.
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From Moreover, our functional analysis revealed that this constitutively activated signaling axis contributes to the survival and proliferation of AML cells. Since activation of STAT3 and STAT5 seems to be an important event for AML initiation and maintenance, and for leukemic stem cell self-renewal [14] [15] [16] [17] and since it is frequently encountered in FLT3-ITD-negative cases 18 , information about druggable upstream activators of STATs in AML is potentially interesting.
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Methods

Cells and reagents
Peripheral blood samples were obtained from AML patients at diagnosis or relapse with the approval of the ethics committee of the Johann Wolfgang Goethe University Frankfurt Metabolic labeling of KG-1 cells with stable isotopes of arginine and lysine (SILAC) was performed as described 19 with the exception that the final concentrations of arginine and lysine were 60 mg/L and 120 mg/L respectively.
To stimulate the Fc-γ Receptor I, cells were treated with monoclonal antibodies for indicated time points as described previously 20 . To induce Mac-1 clustering, cells were treated with immobilized anti-α M F(ab) 2 fragments of LPM19c for indicated durations as described previously 21 . Antibodies and further reagents are outlined in the Supplemental Materials and
Methods.
Immunoprecipitation experiments and Immunoblotting
Syk, SLP65 and FcRγ were immunoprecipitated from 10 7 KG-1 cells using 2μg of the respective antibodies per sample as described previously 24 . In addition, Syk was immunoprecipitated from 5*10 6 cells of the primary AML cell lines. Immunoblotting was performed as described previously
24
.
Mass spectrometric analysis, database search and MaxQuant-based protein quantification
Proteins were separated by one-dimensional SDS-PAGE (4-12% NuPAGE Bis-Tris Gel, Invitrogen, USA) and the entire lane of the Coomassie blue-stained gel was cut into 23 slices. All slices were processed as detailed in the Supplemental Materials and Methods.
In vitro kinase assays
To test for the ability of Syk to phosphorylate the tyrosine residues 705 and 694 of STAT3 and STAT5, respectively, a kinase assay was performed using the biotinylated peptides EHPEADPGSAAPYLKTKFIC for STAT3 and TPVLAKAVDGYVKPQIK for STAT5 (Pierce, Rockford, USA). The kinase assay was performed as detailed in Supplemental Materials and
Methods.
Flow cytometry
GFP expression of transduced KG-1 cells as well as CD34 expression were assessed by flow cytometry on a FACS Canto II instrument.
Cell proliferation assay
Cell proliferation was measured by an XTT-based method according to the protocol of the cell proliferation kit II (Roche) as outlined in the Supplemental Materials and Methods. (Fig. 1F) . In contrast to the primary AML cell cultures, CD34 expression was not altered in KG-1 cells after knock-down of Syk ( Fig. 1F ). Taken together, the results indicate significant tonic signaling in AML cells that involves Syk activation and leads to proliferation.
The Syk interactome in AML cells
To gain insight into Syk-driven signaling pathways, we characterized the Syk complex in AML cells. In order to identify interaction partners of Syk we performed a "protein interaction screen by quantitative immunoprecipitation combined with knockdown" (QUICK) analysis 25 .
The experimental set-up is outlined in Fig. 2A . KG-1 cells were left unlabeled ("light" (L)) or were metabolically labeled via SILAC with "heavy" (H) stable isotopes of lysine and arginine.
Syk was subsequently knocked down by a Syk-specific shRNA in the L-KG-1 cell batch. The efficiency of the Syk knockdown is demonstrated in Fig. 2B . Upon
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In AML cells, the interactome analysis revealed 18 proteins as Syk ligands (Table 1 and   supplementary table 4 (Fig. 3C) . Moreover, we observed strongly reduced expression of the STAT3/5 target genes pim1 and socs3 in the Syk knock-down cells (Fig. 3D ).
To investigate whether Syk directly activates STAT3 and STAT5, we performed an in vitro kinase assay utilizing biotinylated peptides encompassing the activation-inducing tyrosine motifs of STAT3 and STAT5. Affinity-purified Syk from untreated KG-1 cells was subjected to this kinase assay. Both STAT3 and STAT5 derived peptides were phosphorylated by Syk in vitro ( Fig. 3E/F, left panels) . We conclude from these experiments that Syk activates STAT3 and STAT5 by phosphorylating Tyr 705 of STAT3 and Tyr 694 of STAT5, presumably through direct interaction. To exclude finally the possibility that a kinase potentially copurified with Syk might contribute to phosphorylation of the STAT peptides, we subjected both peptides to the action of a recombinant enzymatically active kinase domain of Syk. As shown in Figure 3E /F (right panels) we detected again tyrosine phosphorylation of Tyr 705
and Tyr 694, thus confirming that Syk is able to phosphorylate STAT3 and STAT5 directly. 
Constitutively active STAT3 and STAT5 counteract the effects of Syk inhibition
Activation mechanisms of Syk/STAT signaling in AML cells
The constitutive In most studied cell systems, activation of Src kinases and Syk has been shown to be controlled by cell surface receptors
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. As described above, we identified an interaction of both cell surface receptors Fc-γRI and Mac-1 with Syk (Table 1) . We found that both Syk and STAT3/5 phosphorylation were reduced but still detectable in Mac-1 knock-down cells (Fig. 6B ). Thus we hypothezised that other β 2 -integrins might redundantly activate Syk. To test this, we knocked down CD18 in FFM05 and FFM12 cells and analyzed proliferation as well as the activation state of the Syk-STAT signaling axis in the co-culture model mentioned above. We observed that proliferation of CD18 knock-down cells which nearly lack β 2 -intergin expression is reduced to a greater extend as compared to Mac-1 knock-down cells (Fig. 6C) . Moreover, activation of Syk, STAT3 and STAT5 is barely detectable in CD18 knock-down cells supporting our hypothesis regarding redundant functions of β 2 -integrin family members (Fig. 6D ). Finally we tested, if the ITAM-containing Fc-γ chain that was shown to link integrins to Syk, is needed to promote proliferation in the AML/stroma co-culture model. This analysis revealed a strong reduction of proliferation in AML cells with diminished Fc-γ chain expression and again activation of the Syk-STAT signaling axis was significantly reduced (Fig. 6E/F ). Of note, we also designed experiments, supervised the project and wrote the paper.
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